Screener
10x Genomics, Inc. TXG Americas (excluding United States) — Revenue
Other geography segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by 10x Genomics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The source filing: 10x Genomics, Inc.’s 10-Q, filed August 7, 2026.
- Filed
- Aug 6, 2026, 8:00 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-054491
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Americas | ||||
| United States(1) | $82,109 | $103,491 | $158,802 | $190,309 |
| Americas (excluding United States) | 2,917 | 2,667 | 6,323 | 6,419 |
| Total Americas | 85,026 | 106,158 | 165,125 | 196,728 |
| Europe, Middle East and Africa | 39,972 | 34,734 | 76,824 | 66,629 |
| Asia-Pacific | ||||
| China | 14,968 | 23,170 | 30,805 | 40,053 |
| Asia-Pacific (excluding China) | 11,070 | 8,846 | 29,125 | 24,381 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is 10x Genomics, Inc.'s americas (excluding united states) — revenue?
- 10x Genomics, Inc. (TXG) reported americas (excluding united states) — revenue of $2.92M in Q2 2026.
- How has 10x Genomics, Inc.'s americas (excluding united states) — revenue changed year-over-year?
- 10x Genomics, Inc.'s americas (excluding united states) — revenue increased by 9.4% year-over-year, from $2.67M to $2.92M.
- What is the long-term trend for 10x Genomics, Inc.'s americas (excluding united states) — revenue?
- Over 4 years (2021 to 2025), 10x Genomics, Inc.'s americas (excluding united states) — revenue has grown at a 16.2% compound annual growth rate (CAGR), from $6.71M to $12.26M.
- What does americas (excluding united states) — revenue mean?
- This metric represents the total revenue generated from sales of instruments, consumables, and software within the Americas region, specifically excluding the United States. It serves as a key indicator of the company's market penetration and commercial success in neighboring North and South American markets. Tracking this figure helps investors assess geographic diversification and the effectiveness of regional sales strategies outside of the primary domestic market.
Ask your AI about 10x Genomics, Inc.'s americas (excluding united states) — revenue.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude